Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
Mariapia Guerrieri, Beatrice Francavilla, Denise Fiorelli, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1499-1499
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Jinyi Tang, Cong Zeng, Thomas M Cox, et al.
Science Immunology (2022) Vol. 7, Iss. 76
Open Access | Times Cited: 257
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Michael W. Russell, Jiří Městecký
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 77
Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients
Santosh Dhakal, Tong Yu, Anna Yin, et al.
Open Forum Infectious Diseases (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
Rupsha Fraser, Aurelio Orta‐Resendiz, Alexander Mazein, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 255-267
Open Access | Times Cited: 31
T cell immune memory after covid-19 and vaccination
Lulu Wang, Alexander R. Nicols, Lance Turtle, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000468-e000468
Open Access | Times Cited: 25
COVID-19 vaccines: Immune correlates and clinical outcomes
Shant H. Mahrokhian, Lisa H. Tostanoski, Samuel J. Vidal, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 8
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
Abbass Darwich, Chiara Pozzi, Giulia Fornasa, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 5
Open Access | Times Cited: 34
Prevalence of olfactory dysfunction in D614G, alpha, delta and omicron waves: a psychophysical case-control study
Luigi Angelo Vaira, Jérôme R. Lechien, Giovanna Deiana, et al.
Rhinology Journal (2022)
Closed Access | Times Cited: 28
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
Nora Pisanic, Annukka A.R. Antar, Kate Kruczynski, et al.
Journal of Immunological Methods (2023) Vol. 514, pp. 113440-113440
Open Access | Times Cited: 13
Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2
Olaf Nickel, Alexandra Rockstroh, Johannes Wolf, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0263861-e0263861
Open Access | Times Cited: 20
Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination
Aya Ishizaka, Michiko Koga, Taketoshi Mizutani, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming
Zhe Zhang, Shipo Wu, Yawei Liu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort
Erika Zecca, Manuela Rizzi, Stelvio Tonello, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1766-1766
Open Access | Times Cited: 16
Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19
Marina Mazzilli Ortega, Laís Teodoro da Silva, Erika Donizette Candido, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome
Gwenny M. Verstappen, Liseth de Wolff, Suzanne Arends, et al.
RMD Open (2022) Vol. 8, Iss. 1, pp. e002265-e002265
Open Access | Times Cited: 13
Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
Mohsen Abdoli, Maryam Shafaati, Ladan Kazem Ghamsari, et al.
Virus Research (2022) Vol. 319, pp. 198857-198857
Open Access | Times Cited: 13
Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review
Eliete Neves Silva Guerra, Vitória Tavares de Castro, Juliana Amorim dos Santos, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2
Ericka Kirkpatrick Roubidoux, Pamela H. Brigleb, Kasi Vegesana, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial
Jiawei Xu, Busen Wang, Ping Gao, et al.
Emerging Microbes & Infections (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases
Shinya Yokote, Hiroyuki Ueda, Akihiro Shimizu, et al.
CEN Case Reports (2022) Vol. 11, Iss. 4, pp. 499-505
Open Access | Times Cited: 10
A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects
Emanuela Martinuzzi, Jonathan Benzaquen, Olivier Guérin, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 12, pp. 2053-2059
Open Access | Times Cited: 10
Primary Exposure to SARS-CoV-2 via Infection or Vaccination Determines Mucosal Antibody-Dependent ACE2 Binding Inhibition
Janeri Fröberg, Vera Koomen, Christa E. van der Gaast–de Jongh, et al.
The Journal of Infectious Diseases (2023)
Open Access | Times Cited: 5
Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients
Zhe Zhang, Shipo Wu, Yawei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Microfluidic particle counter visualizing mucosal antibodies against SARS-CoV-2 in the upper respiratory tract for rapid evaluation of immune protection
Jiaheng Li, Lok Ting Chu, Hogi Hartanto, et al.
Lab on a Chip (2024) Vol. 24, Iss. 10, pp. 2658-2668
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top